Bain Capital Life Sciences Investors’s Jiya Acquisition Corp. Class A Common Stock JYAC Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio JYAC Stock Details JYAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300,000	Closed	-$2.95M	–	37
2022 Q1	$2.95M	Hold	300,000	–	–	0.29%	34
2021 Q4	$2.93M	Hold	300,000	–	–	0.23%	34
2021 Q3	$2.92M	Hold	300,000	–	–	0.18%	32
2021 Q2	$2.98M	Hold	300,000	–	–	0.2%	29
2021 Q1	$2.95M	Hold	300,000	–	–	0.17%	30
2020 Q4	$3.09M	Buy	+300,000	New	+$3.05M	0.19%	25

Other funds holding JYAC

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bain Capital Life Sciences Investors's JYAC Position: Q2 2022 in Review

Bain Capital Life Sciences Investors sold out of Jiya Acquisition Corp. Class A Common Stock (JYAC) in Q2 2022, closing a stake of 300,000 shares — an estimated $2.95M sold.

Bain Capital Life Sciences Investors first reported a position in JYAC in Q4 2020 and held it in 6 quarters. The position peaked at $3.09M in Q4 2020. 54 funds tracked by Wall St. Rank hold JYAC as of Q2 2022.

Bain Capital Life Sciences Investors reported no remaining Jiya Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Bain Capital Life Sciences Investors sold 300,000 Jiya Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $2.95M.
Bain Capital Life Sciences Investors first reported a position in Jiya Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Bain Capital Life Sciences Investors's Jiya Acquisition Corp. Class A Common Stock position peaked at $3.09M in Q4 2020.
54 funds tracked by Wall St. Rank held Jiya Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Bain Capital Life Sciences Investors's 13F filing for Q2 2022, filed 15 Aug 2022.